SciCombinator

Discover the most talked about and latest scientific content & concepts.

G Long, R Mortimer and G Sanzenbacher
Abstract
Abstract Objective: To investigate the evolving use and expected impact of pay-for-performance (P4P) and risk-based provider reimbursement on patient access to innovative medical technology. Methods: Structured interviews with leading private payers representing over 110 million commercially-insured lives exploring current and planned use of P4P provider payment models, evidence requirements for technology assessment and new technology coverage, and evolving relationship between the two topics. Results: Respondents reported rapid increases in the use of P4P and risk-sharing programs, with roughly half of commercial lives affected three years ago, just under two-thirds today, and an expected three-quarters in three years. All reported well-established systems for evaluating new technology coverage. Five of nine reported becoming more selective in the past three years in approving new technologies; four anticipated that in the next three years there will be a higher evidence requirement for new technology access. Similarly, four expected it will become more difficult for clinically appropriate but costly technologies to gain coverage. All reported planning to rely more on these types of provider payment incentives to control costs, but didn’t see them as a substitute for payer technology reviews and coverage limitations; they each have a role to play. Limitations: Interviews limited to nine leading payers with models in place; self-reported data. Conclusion: Likely implications include a more uncertain payment environment for providers, and indirectly for innovative medical technology and future investment, greater reliance on quality and financial metrics, and increased evidence requirements for favorable coverage and utilization decisions. Increasing provider financial risk may challenge the traditional technology adoption paradigm, where payers assumed a “gatekeeping” role and providers a countervailing patient advocacy role with regard to access to new technology. Increased provider financial risk may result in an additional hurdle to the adoption of new technology, rather than substitution of provider- for payer-based gatekeeping.
Tweets*
3
Facebook likes*
0
Reddit*
0
News coverage*
0
Blogs*
1
SC clicks
1
Concepts
Technology assessment, Finance, Credit card, Money, Risk, Technology
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com